The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss The Food and Drug Administration on Thursday approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss
FDA approves first gene therapy for genetic hearing lossFDA approves first gene therapy for genetic hearing loss
